Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
出版年份 2022 全文链接
标题
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
作者
关键词
-
出版物
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-06-28
DOI
10.1016/s2213-2600(22)00186-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
- (2022) Victoria Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
- (2022) Catherine J. Reynolds et al. SCIENCE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
- (2022) Robert B M Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- (2022) Carlo Scognamiglio Renner Araujo et al. ANNALS OF THE RHEUMATIC DISEASES
- Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
- (2022) Amanthi Nadira Arumahandi de Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
- (2022) Abhishek Abhishek et al. BMJ Open
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
- (2021) Maria Prendecki et al. LANCET
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1
- (2021) Jeffrey R Curtis et al. Arthritis & Rheumatology
- Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
- (2021) Ian McDonald et al. npj Vaccines
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2021) Liana Fraenkel et al. ARTHRITIS CARE & RESEARCH
- The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- (2021) Alasdair P S Munro et al. LANCET
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- JOINT AAD-NPF GUIDELINES OF CARE FOR THE MANAGEMENT OF PSORIASIS WITH SYSTEMIC NON-BIOLOGICAL THERAPIES
- (2020) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- (2011) M. Herdman et al. QUALITY OF LIFE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More